Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

INHBC

Introduction

Inhibin beta C chain is a protein that in humans is encoded by the INHBC gene.[1][2]

This gene encodes the beta C chain of inhibin, a member of the TGF-beta superfamily. This subunit forms heterodimers with beta A and beta B subunits. Inhibins and activins, also members of the TGF-beta superfamily, are hormones with opposing actions and are involved in hypothalamic, pituitary, and gonadal hormone secretion, as well as growth and differentiation of various cell types.[2]

References

References

  1. ↑ H tten G, Neidhardt H, Schneider C, Pohl J (Feb 1995). “Cloning of a new member of the TGF-beta family: a putative new activin beta C chain”. Biochem Biophys Res Commun. 206 (2): 608–13. doi:10.1006/bbrc.1995.1086. PMID 7826378.
  2. ↑ 2.0 2.1 “Entrez Gene: INHBC inhibin, beta C”.
Further reading

Further reading

  • Bernard DJ, Chapman SC, Woodruff TK (2001). “Mechanisms of inhibin signal transduction”. Recent Prog. Horm. Res. 56: 417–50. doi:10.1210/rp.56.1.417. PMID 11237224.
  • Mathews LS, Vale WW (1991). “Expression cloning of an activin receptor, a predicted transmembrane serine kinase”. Cell. 65 (6): 973–82. doi:10.1016/0092-8674(91)90549-E. PMID 1646080.
  • Schmitt J, Hötten G, Jenkins NA, et al. (1997). “Structure, chromosomal localization, and expression analysis of the mouse inhibin/activin beta C (Inhbc) gene”. Genomics. 32 (3): 358–66. doi:10.1006/geno.1996.0130. PMID 8838799.
  • Thomas TZ, Chapman SM, Hong W, et al. (1998). “Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia”. Prostate. 34 (1): 34–43. doi:10.1002/(SICI)1097-0045(19980101)34:1<34::AID-PROS5>3.0.CO;2-K. PMID 9428386.
  • Mellor SL, Cranfield M, Ries R, et al. (2001). “Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit”. J. Clin. Endocrinol. Metab. 85 (12): 4851–8. doi:10.1210/jc.85.12.4851. PMID 11134153.
  • Casagrandi D, Bearfield C, Geary J, et al. (2003). “Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia”. Mol. Hum. Reprod. 9 (4): 199–203. doi:10.1093/molehr/gag029. PMID 12651901.
  • Mellor SL, Ball EM, O’Connor AE, et al. (2003). “Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate”. Endocrinology. 144 (10): 4410–9. doi:10.1210/en.2003-0225. PMID 12960042.
  • Ushiro Y, Hashimoto O, Seki M, et al. (2007). “Analysis of the function of activin betaC subunit using recombinant protein”. J. Reprod. Dev. 52 (4): 487–95. doi:10.1262/jrd.17110. PMID 16627954.